CMV Immunity Monitoring in Lung Transplant Recipients

Condition:   Lung Transplant; Complications Interventions:   Device: Cytomegalovirus T Cell Immunity Panel (CMV-TCIP);   Diagnostic Test: Donor-Derived Cell-Free DNA (dd-cfDNA) Assay;   Drug: Valganciclovir Sponsors:   NYU Langone Health;   Viracor Eurofins Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials